Becton, Dickinson and Company (BD) has launched the Incada Connected Care Platform, an AI-powered cloud-based system designed to integrate data from the company’s devices into a unified ecosystem, for healthcare connectivity.
The company released the platform alongside the next-generation Pyxis Pro Automated Medication Dispensing Solution.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
The BD Incada Platform was built on Amazon Web Services’ cloud infrastructure and leverages advanced AI technologies such as natural language analytics.
It can handle data from nearly three million BD devices, providing healthcare professionals with comprehensive visibility into medication inventory.
The system aims to help clinicians identify medication patterns, ensuring availability, reducing waste, and improving labour efficiency.
Users can employ natural language queries to receive AI-driven insights and analytics, which are accessible through customisable dashboards.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataBD Connected Care EVP and president Bilal Muhsin said: “Our vision for the BD Incada Platform is to go beyond legacy connectivity to create meaningful connections across devices from infusion pumps to patient monitors to pharmacy robotics, and unify data from those solutions into one ecosystem, transforming data into clear, actionable insights for care teams.
“These launches represent key milestones in BD’s Connected Care strategy, where we are uniquely positioned with our broad portfolio from pharmacy to bedside, to leverage game-changing technology to drive meaningful benefits for our customers.”
The BD Pyxis Pro Dispensing Solution enhances medication storage and access at the point of care.
Its flexible, stackable design increases storage capacity, accommodating both refrigerated and ambient medications.
This allows healthcare facilities to adapt to varying patient needs without requiring additional space.
The solution also includes improved security measures for controlled substance management and incorporates RFID badge scanning, illuminated bins and wireless barcode scanners to facilitate medication retrieval.
By integrating the Incada Platform with the Pyxis Pro Dispensing Solution, BD aims to set a new benchmark for data-driven healthcare operations
In August 2025, BD announced over $35m investment to expand the manufacturing of BD PosiFlush prefilled flush syringes at its facility in Columbus, Nebraska, US.
